CU Anschutz Cancer Center

Official X page of the University of Colorado Anschutz Cancer Center - Colorado's only @theNCI-designated comprehensive cancer center.

[CU Anschutz Cancer Center @CUCancerCenter]

Carlo Caballero, LPC, CCM, of the Office of Community Outreach and Engagement, has been named in the seventh annual Cancer Health 25 feature dedicated to financial helpers and fundraisers: https://t.co/h2JrUlrwj1

[CU Anschutz Cancer Center @CUCancerCenter]

In this Q&A, CU Anschutz Cancer Center member and Assistant Professor of @CU_Urology in @CUDeptSurg, Jeff Morrison, MD, shares how both cancer and treatments such as chemotherapy, surgery, and radiation affect male fertility: https://t.co/bczcojUYSr

[CU Anschutz Cancer Center @CUCancerCenter]

We have two new endowed chairs: the Dudley Family Endowed Chair in Cancer Excellence, with Jon Vogel, MD, serving as the chairholder; and the Dudley Family Rising Star Endowed Chair, with Michael Oliphant, PhD, named as the inaugural chairholder! Thank you to the Dudley family!

[CU Anschutz Cancer Center @CUCancerCenter]

CU Anschutz Cancer Center's acute myeloid leukemia researchers say that a key to research success is the spirit of collaboration that flourishes across @CUAnschutz.

Read the cover story of the Spring 2026 issue of the C3: https://t.co/Rkymvc6CEa

[CU Anschutz Cancer Center @CUCancerCenter]

CU Anschutz Cancer Center leader Heide Ford, PhD, is researching ways to target the “programs” the cancer cells use to change their state. Read about Ford's work: https://t.co/IQfunWhFj3

[CU Anschutz Cancer Center @CUCancerCenter]

It's #NationalCancerSurvivorsDay. In this article, Jennifer Diamond, MD, discusses the roles of both clinical trial researchers and participants and how they affect the rise in cancer survivorship: https://t.co/lpti8xGPnS

[CU Anschutz Cancer Center @CUCancerCenter]

#NationalCancerSurvivorsDay: Honoring survivors, inspiring the future.

In honor of this day, we've gathered patient stories from over the last year to show that survivorship is not a single milestone but an ongoing, evolving experience: https://t.co/XqAOAUsS9F

[OncLive.com @OncLive]

🤔 Rashes associated with mogamulizumab are common AEs for patients with CTCL, and understanding the AE and how to manage it is crucial for clinical practice according to Brad Haverkos, MD, of @CUCancerCenter

Read more here ➡️: https://t.co/s0ZeQqk5bu

#lymsm #oncology

[Lung Cancer Canada @LungCancer_Can]

🎙️ New podcast episode of Lung Cancer Voices! @pwheatleyprice speaks to @DRCamidge, Director of Thoracic Oncology @CUCancerCenter not only on his clinical expertise on EGFR+ lung cancer, but also his personal journey dx at stage 4 in 2022. Listen now https://t.co/D2ce0QvtKF

[CU Anschutz Cancer Center @CUCancerCenter]

Norm Taylor established an endowed chair, named for his late wife, Katie, to advance and support uterine cancer research at the CU Anschutz Cancer Center: https://t.co/Y0GPByUj0E

[CU Anschutz Cancer Center @CUCancerCenter]

#UterineCancerAwarenessMonth: There are around 68,000 new cases of this disease in the U.S. every year. This number is rising and has made uterine cancer the fourth most common cancer among women. Christine Walsh, MD, MS, shares why ⬇️
https://t.co/y6HwuRADeU

[CU Anschutz Cancer Center @CUCancerCenter]

In our latest Q&A, CU Anschutz Cancer Center's Jill Alldredge, MD, helps us better understand premature menopause and fertility issues induced by cancer treatments ⬇️
https://t.co/MIOTtRmoyC

[CU Anschutz Cancer Center @CUCancerCenter]

CU Anschutz Cancer Center leader Curtis Henry, PhD, and postdoctoral fellow Claire Pillsbury, PhD, are looking at the medications’ effects on cancer and autoimmune disease ⬇️
https://t.co/sWx7sUFzdB

[CU Anschutz Cancer Center @CUCancerCenter]

In this Q&A, CU Anschutz Cancer Center's Rajeev Vibhakar, MD, PhD, talks about his dual role as a clinician and researcher of pediatric brain tumors: https://t.co/RlUrHANDIT

[CU Anschutz Cancer Center @CUCancerCenter]

The @AmericanCancer Society has updated its colorectal cancer screening guidelines. CU Anschutz Cancer Center's Swati Patel, MD, and Andi Dwyer, MPH, share their insights on the changes and what it means for Coloradans: https://t.co/4KRFkyR7bf

[CU Anschutz Cancer Center @CUCancerCenter]

Results from a clinical trial of a CAR T-cell treatment for brain tumors that naturally occur in dogs could eventually lead to a similar clinical trial for pediatric high-grade gliomas: https://t.co/ja6Bh27fjj

[CU Anschutz Lymphoma Program @CULymphoma]

We are one of the first participating sites in the OncoPRO Initiative, now presented at #ASCO26.
We implemented ePRO monitoring @CUCancerCenter (spearheaded by Dr. @majorajay) as part of routine cancer care to better support patients during treatment.
https://t.co/jXVyzhd72m

[CU Anschutz Cancer Center @CUCancerCenter]

The annual Thoracic Oncology Research Initiative (TORI) Lung Cancer SPORE Retreat was held yesterday, where attendees shared their research milestones and updates on ongoing projects and brainstormed future collaborations. Learn more about TORI: https://t.co/OVa36jyxDi

[RUNX1 Research Program @RUNX1Research]

We’re just one week away from our RRP Research Webinar featuring Dr. James DeGregori (@CUCancerCenter).

Join to hear more about how aging reshapes blood stem cells, drives clonal hematopoiesis, and why mutations like TET2 may gain a selective advantage over time, with important implications for leukemia risk.

Register now: https://t.co/QflJ9k8gxd

[CU Anschutz Cancer Center @CUCancerCenter]

Led locally by CU Anschutz Cancer Center's Marie Wood, MD, EvoPAR, a worldwide clinical trial, is investigating a pair of new therapies for advanced breast cancer: https://t.co/HOuCr6ljE9